Genetic Susceptibility to Kidney Cancer
Terminated
- Conditions
- Renal Cell Carcinoma
- Registration Number
- NCT00854022
- Lead Sponsor
- Baylor College of Medicine
- Brief Summary
This study will further the understanding of the genetic events leading to the development of RCC.
- Detailed Description
This study will further the understanding of the genetic events leading to the development of RCC; explore the genetic basis for genetic instability and how it affects cancer risk; and eventually provide a means of identifying a subgroup of individuals who are most likely to develop RCC. Such individuals may then be targeted for intervention programs such as chemoprevention or dietary modification.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
- Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal Cell Carcinoma within the past year.
Exclusion Criteria
- Must not have received chemotherapy, biological therapy or radiation therapy in the 6 months preceding enrollment will
- Must not have had RCC, or metastatic RCC,
- Must not have had a renal transplantation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify interindividual differences in inherited genetic instability 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
MD Anderson Cancer Center
🇺🇸Houston, Texas, United States